Treatment situation for newly diagnosed multiple myeloma (MM) patients in Germany (GER). First results from a representative multicentre treatment survey.

被引：0
|
作者：
Freund, MRF
Knauf, W
Goldschmidt, H
Einsele, H
Nowrousian, MR
Berdel, WE
Poenisch, W
Straka, C
Kellermann, L
Bammer, S
Angermund, R
机构：
[1] Univ Rostock, Rostock, Germany
[2] Onkol Gemeinschaftspraxis, Frankfurt, Germany
[3] Univ Heidelberg, D-6900 Heidelberg, Germany
[4] Univ Wurzburg, D-97070 Wurzburg, Germany
[5] Univ Essen Gesamthsch, Essen, Germany
[6] Univ Munster, D-4400 Munster, Germany
[7] Univ Leipzig, D-7010 Leipzig, Germany
[8] Univ Munich, Klinikum Innenstadt, D-8000 Munich, Germany
[9] Oncol Informat Serv, Freiburg, Germany
[10] ORTHO BIOTECH, Neuss, Germany
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5158
引用
收藏
页码：372B / 373B
页数：2
相关论文
共 50 条
  • [31] Optimizing Treatment for Elderly Patients With Newly Diagnosed Multiple Myeloma: A Personalized Approach
    Larocca, Alessandra
    Palumbo, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (30) : 3600 - +
  • [32] ADDITION OF IMMUNOTHERAPY TO CONVENTIONAL TREATMENT SCHEMES FOR PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Dominguez Alejandra, Blum
    Rodriguez Violeta, Reyes
    Hernandez Esther, Zato
    HAEMATOLOGICA, 2021, 106 (10) : 135 - 136
  • [33] Elderly Patients with Newly Diagnosed Multiple Myeloma: Continuous or Fixed Duration Treatment?
    Manier, Salomon
    Facon, Thierry
    HEMATO, 2024, 5 (02): : 115 - 118
  • [34] TREATMENT OF ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS: NEW THERAPEUTIC INDICATIONS
    Bringhen, S.
    Bonello, F.
    HAEMATOLOGICA, 2021, 106 (10) : 211 - 215
  • [35] Treatment Resistance Risk in Patients with Newly Diagnosed Multiple Myeloma Is Associated with Blood Hypercoagulability: The ROADMAP-MM Study
    Gerotziafas, Grigorios T.
    Fotiou, Despina
    Sergentanis, Theodoros N.
    Papageorgiou, Loula
    Fareed, Jawed
    Falanga, Anna
    Sabbah, Michele
    Garderet, Laurent
    Terpos, Evangelos
    Elalamy, Ismail
    Van Dreden, Patrick
    Dimopoulos, Meletios A.
    HEMATO, 2022, 3 (01): : 188 - 203
  • [36] CCNU, Idarubicin & Dexamethasone (CIDEX) - An effective oral treatment in newly diagnosed and relapsed patients with multiple myeloma (MM.)
    Brito-Babapulle, F
    Giannoutsos, L
    Maboreke, T
    BLOOD, 2001, 98 (11) : 308B - 308B
  • [37] LOW RATE OF SECONDARY PRIMARY MALIGNANCIES (SPMS) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS TREATED WITH LENALIDOMIDE: FIRST RESULTS FROM THE MRC MM XI TRIAL
    Brioli, A.
    Davies, F.
    Gregory, W.
    Hinsley, S.
    Marshall, S.
    Pawlyn, C.
    Cavo, M.
    Jackson, G.
    Russell, N.
    Morgan, G.
    HAEMATOLOGICA, 2013, 98 : 104 - 104
  • [38] ASSESSING THE BENEFIT OF CONTINUOUS TREATMENT IN THE FIRST TRIAL (MM-020): IMPACT OF RESPONSE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA
    Bahlis, N.
    Corso, A.
    Muegge, L. O.
    Shen, Z. X.
    Desjardins, P.
    Stoppa, A. M.
    Decaux, O.
    de Revel, T.
    Granell, M.
    Marit, G.
    Nahi, H.
    Demuynck, H.
    Huang, S. Y.
    Basu, S.
    Ervin-Haynes, A.
    Leupin, N.
    Marek, J.
    Chen, G.
    Facon, T.
    HAEMATOLOGICA, 2015, 100 : 85 - 86
  • [39] Bortezomib-Based Triplet Therapy As First Line Treatment in Newly Diagnosed Multiple Myeloma Patients in Peru
    Vasquez, Jule F.
    Cordova, Naty Lopez
    Castillo, Claudia
    Saavedra, Alexandra
    Calle, Cindy
    Chavez, Lourdes Isabel Lopez
    Alcarraz, Cindy Elizabeth
    Rios, Pedro Eduardo Lovato
    Matuk, Alexandra La Torre
    Laboriano, Jorge
    Vilcarano, Abner
    Tokumura, Carmen
    Quintana, Shirley
    Samanez-Figari, Cesar
    Vidaurre, Tatiana
    BLOOD, 2024, 144 : 6997 - 6998
  • [40] Treatment options and considerations for the newly diagnosed myeloma patient - From the Multiple Myeloma Research Foundation
    Rajkumar, Vincent S.
    ONCOLOGY-NEW YORK, 2005, 19 (10): : 1260 - +
12345